Search for: "Teva Pharmaceuticals" Results 1101 - 1120 of 1,430
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Nov 2009, 3:15 am
Named defendants in the suits are Bayer Healthcare Pharmaceuticals, a German company with U.S. headquarters in Wayne, which makes Yaz and Barr Pharmaceuticals of Montvale, owned Teva Pharmaceuticals of Israel, which makes Ocella, a generic version. [read post]
30 Jul 2009, 11:32 am
v=dum81RdFrhM&feature=player_embedded Unfortunately, both the manufacturer of Reglan (Wyeth Pharmaceuticals) and manufacturers of the generic metoclopramide (Actavis Elizabeth, Teva Pharmaceuticals USA, Pliva and Barr Pharmaceuticals) have placed profits before patient safety. [read post]
31 May 2011, 8:38 pm by Marie Louise
Merial (EPLAW) Neurontin (Gabapentin) – US: Teva settles Pfizer case on generic epilepsy drug with undisclosed terms (GenericsWeb) Noxafil (Posaconazole) – US: Schering files patent infringement complaint against Sandoz in response to Para IV certification (Patent Docs) Patanol (Olopatadine) – US: Alcon wins Patanol patent infringement lawsuit against Apotex (GenericsWeb) Prandin (Repaglinide) – US: Obama Administration urges Supreme Court to grant certiorari in case… [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US:… [read post]
10 Apr 2012, 1:15 pm by Tom Lamb
  The Ocella and Gianvi birth control pills are from Teva Pharmaceuticals and Barr Laboratories; Zarah, a generic version of Yasmin, and Vestura, a generic version of YAZ. [read post]
17 Nov 2020, 9:16 pm by Rik Lambers (Brinkhof)
To almost finish a long post with a long sentence, one fact from that case: in view of the earlier cross-border case law that a Dutch MA holder also acts unlawful if a foreign entity, holding a pharmaceutical authorization, infringes with a generic product, Teva decided that the MA and pharmaceutical authorization should be held by the same entity within the group. [read post]
15 Aug 2019, 9:05 pm by Alana Bevan
District Court for the District of Connecticut against Heritage, Mylan, Teva, and other pharmaceutical manufacturers. [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
13 Feb 2023, 2:40 pm by Matthieu Dhenne (Ipsilon)
Based on the same patent, ONO Pharmaceutical & Professor H. had subsequently filed a second SPC application (No. 16C0001) on January 6, 2016, based on marketing authorization (MA) No. [read post]
19 Oct 2011, 3:30 am by Marie Louise
(IPBiz) US: Patent protection for the BRCA1 gene and genetic diagnostic methods in the USA: AMP v USPTO (JIPLP) US: Marking with an unenforceable patent does not create intent to deceive: Hollander v Hospira (Chicago Intellectual Property Law Blog) US: Regenerative Sciences lawsuit update and FDA’s attempt to broaden the definition of “interstate commerce”: USA v Regenerative Sciences (FDA Law Blog)   Products Embeda (Morphine, Naltrexone) – US: Pfizer, Alpha… [read post]
17 Jul 2009, 1:43 am
Teva Pharmaceuticals USA Inc.INTELLECTUAL PROPERTY - Patents"In granting Eisai's motion to strike in this patent infringement case, the judge erred where she misapplied Rule 9(b) and it cannot be held as a matter of law that Teva's allegations have no possible relation to its defense". [read post]
15 Apr 2010, 4:27 am
(EPLAW) Prevacid (Lansoprazole) – US: Takeda files patent infringement complaint against Zydus following Para IV challenge (Patent Docs) Reyataz (Atazanavir) – US: Bristol-Myer Squibb, Novartis file patent infringement suit against Teva following Para IV challenge (Patent Docs) Treximet (Sumatriptan, Naproxen) – US: POZEN enters into settlement agreement with Teva regarding Para IV patent litigation (SmartBrief) Zerit (Stavudine) – US: Promote Innovation… [read post]
5 May 2014, 8:28 am by Gene Quinn
Unfortunately for Actavis, on April 28, 2014, the FDA awarded sole exclusivity on generic Celebrex® to Teva Pharmaceutical Industries Ltd. [read post]
15 Sep 2010, 2:40 am by Kelly
KG v Apotex Pty Ltd (No 2) (Patentology) MoviPrep – US: Salix and Norgine settle with Novel in patent dispute over MoviPrep (Patent Docs) Nexavar (Sorafenib) – India: Nexavar patent infringement suit before Delhi HC goes directly to trial: Bayer v Cipla (Spicy IP) Simcor (Niacin/Simvastatin) – US: Abbott files patent infringement suit against Teva following Para IV challenge (Patent Docs) Vancocin (Vancomycin) – US: ViroPharma sues FDA over generic Vancocin; alleges… [read post]
29 Apr 2014, 1:39 pm by Barry Barnett
The Supreme Court today granted certiorari in Teva Pharmaceuticals USA, Inc. v. [read post]
3 Mar 2020, 4:00 am by Alan Macek
In Novartis Pharmaceuticals Canada Inc. v. [read post]